These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 2435072

  • 1. [Crucial diagnostic points of tumor markers: gastrointestinal tumors].
    Klöppel G.
    Verh Dtsch Ges Pathol; 1986; 70():159-71. PubMed ID: 2435072
    [No Abstract] [Full Text] [Related]

  • 2. [Tumor markers in gastrointestinal cancer].
    Shimano T, Monden T, Oji Y, Morimoto H, Tomita N, Mori T.
    Rinsho Byori; 1985 Aug; 33(8):853-60. PubMed ID: 3908746
    [No Abstract] [Full Text] [Related]

  • 3. [New monoclonal antibodies in the diagnosis of gastrointestinal cancers].
    Heptner G, Domschke S, Domschke W.
    Internist (Berl); 1986 Nov; 27(11):723-8. PubMed ID: 2433247
    [No Abstract] [Full Text] [Related]

  • 4. The role of tumor markers in the diagnosis and management of gastrointestinal cancer.
    Heptner G, Domschke S, Domschke W.
    Hepatogastroenterology; 1986 Aug; 33(4):140-4. PubMed ID: 2428718
    [No Abstract] [Full Text] [Related]

  • 5. Simultaneous measurements of tumour-associated antigens in gastrointestinal cancer.
    Go VL.
    Clin Gastroenterol; 1976 Sep; 5(3):645-51. PubMed ID: 66112
    [No Abstract] [Full Text] [Related]

  • 6. [Diagnosis of tumors with the use of immunologic tumor markers].
    Vorlaender KO.
    Wien Med Wochenschr; 1983 Feb 15; 133(3):59-66. PubMed ID: 6189301
    [No Abstract] [Full Text] [Related]

  • 7. [Immunological methods in tumor diagnosis].
    Jaquet H, Mach JP, Pettavel J.
    Verh Dtsch Ges Inn Med; 1978 Feb 15; (84):567-72. PubMed ID: 84451
    [No Abstract] [Full Text] [Related]

  • 8. [Tumor markers in digestive oncology: present status of the topic and prospects for the future].
    Desaive C.
    Rev Med Liege; 1987 Nov 15; 42(22):881-7. PubMed ID: 2447625
    [No Abstract] [Full Text] [Related]

  • 9. [Ganglioside and carcinoembryonic antigens in the diagnosis of malignant tumors of the gastrointestinal tract].
    Ivanov PK, Samoĭlenko VM.
    Vopr Onkol; 1984 Nov 15; 30(9):55-9. PubMed ID: 6495695
    [Abstract] [Full Text] [Related]

  • 10. [An overview of tumor markers].
    Morita R, Fukunaga M, Ohtsuka N.
    Rinsho Hoshasen; 1986 Jan 15; 31(1):1-10. PubMed ID: 2422414
    [No Abstract] [Full Text] [Related]

  • 11. Oncofetal and other tumor-associated antigens of the human digestive system.
    Goldenberg DM.
    Curr Top Pathol; 1976 Jan 15; 63():289-342. PubMed ID: 64333
    [No Abstract] [Full Text] [Related]

  • 12. [The tumor-associated antigen CA 19-9 in the differential diagnosis and course control of malignancies of the pancreas and the gastrointestinal tract].
    Klapdor R, Greten H.
    Dtsch Med Wochenschr; 1984 Dec 14; 109(50):1935-9. PubMed ID: 6210188
    [No Abstract] [Full Text] [Related]

  • 13. Simultaneous radioimmunoassay for carcinoembryonic antigen (CEA) and alpha-fetoprotein (alphaFP) in neoplasms of the gastro-intestinal tract.
    McIntire KR, Waldmann TA, Go VL, Moertel CG, Ravry M.
    Ann Clin Lab Sci; 1974 Dec 14; 4(2):104-8. PubMed ID: 4819750
    [No Abstract] [Full Text] [Related]

  • 14. Tumor markers in testis tumors.
    Kansu E.
    Turk J Pediatr; 1984 Dec 14; 26(1-4):277-83. PubMed ID: 6085661
    [No Abstract] [Full Text] [Related]

  • 15. Monoclonal antibodies in the diagnosis and treatment of malignant conditions.
    Allum WH, Macdonald F, Fielding JW.
    Surg Annu; 1986 Dec 14; 18():41-64. PubMed ID: 2417343
    [No Abstract] [Full Text] [Related]

  • 16. [CA-19-9, CA50 and CEA in pancreatic and gastrointestinal tumors. Comparative studies].
    Dienst C, Clodius T, Oldörp T, Uhlenbruck G, Diehl V.
    Med Klin (Munich); 1987 Jan 30; 82(2):45-50. PubMed ID: 3470595
    [No Abstract] [Full Text] [Related]

  • 17. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G, Piantino P, Cerchier A, Pecchio F.
    Minerva Med; 1985 Apr 14; 76(16):765-70. PubMed ID: 2582313
    [Abstract] [Full Text] [Related]

  • 18. Immunological diagnosis and prognosis of digestive tract cancer: some clinical considerations.
    Zamcheck N.
    Ann Immunol (Paris); 1973 Nov 14; 124(4):635-40. PubMed ID: 4792503
    [No Abstract] [Full Text] [Related]

  • 19. [Early diagnosis of cancer using monoclonal antibodies].
    Ohkura H.
    Nihon Rinsho; 1985 Jul 14; 43(7):1525-34. PubMed ID: 2414489
    [No Abstract] [Full Text] [Related]

  • 20. [Evaluation of a monoclonal antibody (CA 19-9 system) in gastrointestinal disease--in comparison with CEA and IAP].
    Furukawa M, Kozaka S, Kushibiki K, Ashida Y, Saito H, Yamamoto H, Furukawa T.
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb 20; 20(1):25-30. PubMed ID: 3858395
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.